Innomar Strategies

What Innomar Strategies does

Innomar Strategies is a Canadian specialty pharmaceutical commercialization services provider founded in 2001 and headquartered in Oakville, Ontario. It operates as a wholly-owned subsidiary of Cencora Inc. (formerly AmerisourceBergen) and serves pharmaceutical manufacturers seeking to enter or expand within the Canadian market. The company delivers an integrated service portfolio covering patient support programs (PSPs), specialty pharmaceutical distribution and third-party logistics (3PL), regulatory affairs and operations, market access consulting, pharmacovigilance, clinical services, and a national pharmacy network. Its distribution and care delivery infrastructure includes 14 pharmacies in every province, over 165 clinics nationwide, dedicated distribution facilities in Milton and (newly opened November 2023) Ontario, and a field/home-based nursing workforce of more than 700 nurses supporting 3,000+ total team members.

The company's technology layer is centered on AvidityHealth, a digital health platform launched in March 2019 that connects patients, healthcare providers, and PSPs. Through partnerships with TELUS Health and Auxita, AvidityHealth integrates electronic medical record (EMR) enrollment so physicians can enroll patients into manufacturer PSPs directly from their EMR systems. Sub-brands Innomar Pharmacy, Innomar Clinics, and InnomarConsulting structure the care delivery and consulting surface, and wholly-owned subsidiaries (HealthForward Inc., Cameron Stewart LifeScience Canada Inc., Apluspharma Ltd., and Innomar Pharmacy Inc.) sit underneath the corporate entity.

Innomar's revenue model is B2B managed services and professional services: manufacturers contract Innomar to operate PSPs, distribute specialty products, navigate Canadian regulatory and reimbursement pathways, and deliver clinical and pharmacy services to patients. Customer segmentation is dual — pharmaceutical manufacturers (both those entering Canada and those already established domestically) and the patients/providers served through manufacturer-sponsored programs. Pricing is not publicly disclosed and engagements are tailored per therapeutic area and client; go-to-market is sales-led and relationship-driven, supported by thought leadership at Canadian healthcare policy events. In 2020, Innomar notably extended its distribution channel by partnering with FedEx Express Canada to distribute Moderna's COVID-19 vaccine nationwide, illustrating the scalability of its specialty distribution platform.

Name

Innomar Strategies

Legal name

Innomar Strategies Inc.

Website

https://innomar-strategies.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Innomar Strategies is a Canadian B2B commercialization partner for pharmaceutical manufacturers, delivering integrated patient support programs, specialty distribution, clinics, pharmacy, and regulatory and market access services across Canada.

Ownership category

akta.pro rank

Product category

Specialty pharmaceutical commercialization services

NAICS

Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

akta.pro secondary industry

Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN)

Keywords

• Specialty pharmaceutical distribution
• Patient support programs
• Pharmaceutical commercialization services
• Regulatory affairs consulting
• Market access consulting

Headquarters

HQ city

Oakville

HQ country

Canada

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Support Programs: Manages patient support programs on behalf of pharmaceutical manufacturer clients, providing coordination, reimbursement support, and care delivery services.
2. Specialty Distribution & 3PL: Third-party logistics and specialty distribution services for pharmaceutical manufacturers, including importation and supply chain management.
3. Regulatory & Consulting Services: Market access consulting, regulatory affairs, regulatory operations, and quality assurance consulting for pharmaceutical companies entering or operating in the Canadian market.
4. Clinical Services: Clinic and nursing services, pharmacy services, and home healthcare delivery across Canada's network of over 160 clinics and 14 pharmacies.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels3 records

Core offering

Innomar Strategies is a Canadian pharmaceutical commercialization partner that delivers an integrated suite of services for specialty drug manufacturers, including Patient Support Programs, specialty distribution and 3PL, regulatory affairs, market access consulting, pharmacovigilance, and clinical services. Service delivery is supported by a coast-to-coast network of over 165 clinics, 14 specialty pharmacies, and 700+ nursing staff, anchored by the AvidityHealth digital platform that enables EMR-based patient enrollment. The company operates as a wholly-owned subsidiary of Cencora Inc. (formerly AmerisourceBergen).

Product overview

Innomar Strategies operates as an integrated healthcare services platform providing end-to-end commercialization support for pharmaceutical manufacturers in Canada. The portfolio consists of core service lines (Patient Support Programs, Specialty Distribution, Regulatory Services, Market Access Consulting, Pharmacovigilance, and Clinics and Nursing) combined with branded care delivery networks (Innomar Clinics with 165+ locations, Innomar Pharmacy with nationwide coverage, and Oncology Support services). The AvidityHealth digital platform serves as the technology layer enabling EMR integration and patient connectivity. This integrated model connects manufacturers seeking Canadian market entry with patients requiring specialty medications through coordinated clinical, logistics, regulatory, and support services.

Differentiator

Problem solved

Functional benefit

Brands

• AvidityHealth: Digital health solution suite launched in March 2019 that enhances patient journey by simplifying connectivity in healthcare and facilitating communication between patients, healthcare professionals, and Patient Support Programs. Includes EMR enrollment services integrated with TELUS Health and Auxita.
• Innomar Pharmacy
• Innomar Clinics
• InnomarConsulting

Products and services

• Patient Support Programs Integrated patient support programs that provide coordination, reimbursement support, and adherence services for patients on specialty medications on behalf of pharmaceutical manufacturer clients.
• Specialty Distribution and 3PL Third-party logistics and specialty pharmaceutical distribution services including importation, warehousing, and cold chain management for pharmaceutical manufacturers entering or operating in Canada.
• Regulatory Services Comprehensive regulatory affairs support including Health Canada submissions, product monograph management, quality assurance consulting, and regulatory operations for pharmaceutical manufacturers.
• Market Access Consulting Strategic consulting services to help pharmaceutical manufacturers navigate Canadian market access, reimbursement strategies, and payer negotiations.
• Pharmacovigilance Drug safety services including adverse event reporting, product quality complaint monitoring, and regulatory safety reporting for pharmaceutical manufacturers.
• Clinics and Nursing Services Clinical care delivery including field nursing services, home healthcare, and in-clinic patient care across Innomar's network of more than 165 clinics across Canada.
• 3PL and Importation Services Third-party logistics and importation services for pharmaceutical manufacturers operating in Canada, supporting cross-border supply and import regulatory compliance.
• Innomar Pharmacy Network Specialty pharmacy network with pharmacies in every Canadian province providing patient access to complex treatments and specialty medications.
• Innomar Clinics Network Network of over 165 clinics across Canada providing infusion services, nursing care, and in-person patient support to specialty medication patients.
• AvidityHealth Digital Health Platform Digital health platform enabling connectivity between healthcare stakeholders, EMR integration for patient enrollment through partnerships with TELUS Health and Auxita, and patient engagement through digital tools.
• Quality Assurance Consulting Quality assurance consulting supporting pharmaceutical manufacturers with quality systems, compliance, and quality-related regulatory requirements in Canada.
• Regulatory Operations Operational support for regulatory submissions, product monograph management, and lifecycle maintenance for pharmaceutical clients.

Quantifiable outcome

• Over 165 clinics and 14 pharmacies provide coast-to-coast patient access
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature2 records

Partnerships

Three partnerships are on record, tiered core and flagship.

• TELUS HealthcoreTechnology or Integration · 13 March 2019Partnership for electronic medical records (EMR) integration through AvidityHealth platform. TELUS Health integration enables physicians to enroll patients into Patient Support Programs directly from their EMR systems, reducing administrative burden and accelerating patient access to therapy.
• AuxitacoreTechnology or Integration · 13 March 2019EMR integration partnership enabling automated enrollment service through AvidityHealth platform. This collaboration serves the majority of EMRs in the specialty healthcare space, facilitating end-to-end digital connectivity for patient program enrollment.
• Cencora (formerly AmerisourceBergen)flagshipOthersCencora is the parent company of Innomar Strategies, providing global connectivity and resources. Innomar applies Cencora's global expertise to Canadian communities, working together toward healthier lives. As part of the Cencora family, Innomar connects creators and caregivers across the global healthcare network.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Bayshore HealthCare: Canadian home and community health provider with national nursing footprint and specialty pharma infusion services, overlapping with Innomar's clinics, field nursing and home-based care delivery.
• Accuristix: Canadian pharmaceutical third-party logistics (3PL) provider offering specialty distribution and supply chain services for manufacturers, directly comparable to Innomar's specialty distribution and importation capabilities.
• Sentrex Health Solutions: Canadian specialty pharma service provider offering patient support programs, specialty distribution and pharmacy services to manufacturers, a direct competitor in the Canadian PSP and specialty distribution market.
• BioScript Solutions: Canada's largest specialty pharmacy and patient support network, providing specialty drug distribution, infusion services and patient support programs across Canada — directly comparable to Innomar's integrated specialty commercialization model.
• McKesson Canada: Operates pharmaceutical distribution, specialty pharmacy and patient support services in Canada, overlapping with Innomar's distribution, specialty pharmacy and PSP offerings and serving many of the same manufacturer clients.

Broad incumbents

• Shoppers Drug Mart (Loblaw Companies): Canada's largest retail pharmacy chain with a Specialty Health Network offering specialty pharmacy and patient support, competing for specialty dispensing and chronic-condition pharmacy volume.
• Cencora Inc. Parent company of Innomar Strategies; one of the largest global pharmaceutical distributors and healthcare services platforms, providing scale and resource leverage that anchors Innomar's competitive position.

Others

• World Courier (Cencora): Sister Cencora subsidiary specializing in time-critical and temperature-controlled pharmaceutical logistics globally; adjacent capability for high-value specialty and biologic distribution that intersects with Innomar specialty distribution.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/innomar-strategies

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innomar Strategies